Mitochondria

Dr Nir Barzilai: Creating a template for all aging trials

There are few voices in Longevity research as distinctive as Dr Nir Barzilai’s. Brimming with jokes and references, his sentences digress and then return to...

Taking life-extending drug Rapamycin to the next level

Life extension studies fly the flag for Rapamycin – a clever drug with humble origins – now a US research team is taking matters...

Metformin could limit the health benefits of exercise

Report finds that anti-diabetic drug metformin could make exercise less effective at improving health but aging researchers remain upbeat. Metformin has been, for a long...

Parkinson’s charity backs new biotech NRG Therapeutics

Parkinson’s UK charity strikes a £1 million deal partnership with NRG Therapeutics for developing drugs aimed at mitochondria. The UK’s leading charity for this disease...

Latest articles

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.